कृपया अन्य खोज का प्रयास करें
Viracta Therapeutics, Inc., a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. Its lead product candidate is Nana-val, an all-oral combination therapy of its proprietary investigational drug, nanatinostat, and the antiviral agent valganciclovir. The company’s Nana-val is in various ongoing clinical trials, including NAVAL-1, an open-label Phase 2 basket trial for the treatment of multiple subtypes of relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as well as an open-label Phase 1b/2 trial for the treatment of EBV+ recurrent or metastatic nasopharyngeal carcinoma and other EBV+ solid tumors. Its product pipeline also includes vecabrutinib, a clinical-stage product candidate; and VRx-510, a preclinical product candidate. The company is headquartered in Cardiff, California.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Ivor Royston | 78 | 2007 | Director |
Thomas Eric Darcy | 73 | 2021 | Independent Director |
Stephen Rubino | 66 | 2021 | Independent Director |
Barry J. Simon | 59 | 2021 | Independent Director |
Mark Andrew Rothera | 61 | 2022 | CEO, President & Director |
Roger James Pomerantz | 67 | 2020 | Independent Chairman of the Board |
Robert Baiocchi | - | 2018 | Member of Scientific Advisory Board |
Ronald Levy | - | 2018 | Member of Scientific Advisory Board |
Jane F. Barlow | 63 | 2021 | Independent Director |
Daniel Douglas Von Hoff | 76 | - | Member of Scientific Advisory Board |
Lawrence S. Young | - | 2018 | Member of Scientific Advisory Board |
Pierluigi Porcu | - | 2018 | Member of Scientific Advisory Board |
Flavia Borellini | 65 | 2021 | Independent Director |
Samuel Lafayette Murphy | 46 | 2019 | Independent Director |
Carl H. June | 70 | 2018 | Member of Scientific Advisory Board |
Gavin Giovannoni | - | 2024 | Member of Scientific Advisory Board |
Shannon Kenney | - | - | Member of Scientific Advisory Board |
Jane Chung | 52 | 2022 | Independent Director |
Douglas V. Faller | - | - | Scientific Founder & Chairman of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है